Vanguard Group »

Alaunos Therapeutics Inc - US shares owned by Vanguard Group

Quarter-by-quarter ownership of Alaunos Therapeutics Inc - US shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Alaunos Therapeutics Inc - US

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics Inc - US held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics Inc - US by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $440k 629k 0.70
2024-03-31 $1.1M 629k 1.81

More positions owned by Vanguard Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Alaunos Therapeutics Inc - US

Vanguard Group
BlackRock
State Street Corporation
PFG Investments
Morgan Stanley
Two Sigma Securities
Tower Research Capital
Steward Partners Investment Advisory
Qube Research & Technologies
Tucker Asset Management

View all funds holding Alaunos Therapeutics Inc - US